NCT00804193View on ClinicalTrials.gov

Safety and Equivalence of a Generic Ciclopirox Olamine Topical Suspension Compared to the Reference Ciclopirox Topical Suspension 0.77% for the Treatment of Tinea Pedis

NACompletedINTERVENTIONAL
Enrollment

553

Participants

Timeline

Start Date

June 30, 2004

Primary Completion Date

December 31, 2004

Study Completion Date

April 30, 2005

Conditions
Tinea Pedis
Interventions
DRUG

Ciclopirox Olamine Topical Suspension

topical suspension

DRUG

Ciclopirox Topical Suspension 0.77%-Reference Product

topical suspension

DRUG

Ciclopirox Olamine Topical Suspension-Placebo

topical suspension

Sponsors

Lead Sponsor

Padagis LLC
All Listed Sponsors
lead

Padagis LLC

INDUSTRY

NCT00804193 - Safety and Equivalence of a Generic Ciclopirox Olamine Topical Suspension Compared to the Reference Ciclopirox Topical Suspension 0.77% for the Treatment of Tinea Pedis | Biotech Hunter | Biotech Hunter